![Frontiers | Accelerator or Brake: Immune Regulators in Malaria | Cellular and Infection Microbiology Frontiers | Accelerator or Brake: Immune Regulators in Malaria | Cellular and Infection Microbiology](https://www.frontiersin.org/files/Articles/610121/fcimb-10-610121-HTML/image_m/fcimb-10-610121-g001.jpg)
Frontiers | Accelerator or Brake: Immune Regulators in Malaria | Cellular and Infection Microbiology
![CD40L Priming of Platelets via NF‐κB Activation is CD40‐ and TAK1‐Dependent | Journal of the American Heart Association CD40L Priming of Platelets via NF‐κB Activation is CD40‐ and TAK1‐Dependent | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/b46fad27-63f8-4758-a067-aa8997cb5457/jah33677-fig-0001.png)
CD40L Priming of Platelets via NF‐κB Activation is CD40‐ and TAK1‐Dependent | Journal of the American Heart Association
![Nitric oxide inhibits IFN regulatory factor 1 and nuclear factor-κB pathways in rhinovirus-infected epithelial cells - Journal of Allergy and Clinical Immunology Nitric oxide inhibits IFN regulatory factor 1 and nuclear factor-κB pathways in rhinovirus-infected epithelial cells - Journal of Allergy and Clinical Immunology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b084534d-99ea-43ff-8dd2-8207f3dbd13b/gr1.jpg)
Nitric oxide inhibits IFN regulatory factor 1 and nuclear factor-κB pathways in rhinovirus-infected epithelial cells - Journal of Allergy and Clinical Immunology
![Biomedicines | Free Full-Text | Immunoglobulins or Antibodies: IMGT® Bridging Genes, Structures and Functions | HTML Biomedicines | Free Full-Text | Immunoglobulins or Antibodies: IMGT® Bridging Genes, Structures and Functions | HTML](https://www.mdpi.com/biomedicines/biomedicines-08-00319/article_deploy/html/images/biomedicines-08-00319-g001.png)
Biomedicines | Free Full-Text | Immunoglobulins or Antibodies: IMGT® Bridging Genes, Structures and Functions | HTML
![An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors | Clinical Cancer Research An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors | Clinical Cancer Research](https://clincancerres.aacrjournals.org/sites/default/files/highwire/clincanres/22/8.cover-source.jpg)